Definitive Contract 36C26226C0179
- Not listed
- Roche Diagnostics Corporation received a delivery order award from Veterans Integrated Service Network 4 (VISN 4) with a ceiling value of $343,594.91 for IT equipment to extend the period of performance for Roche Ventana slide processing systems. The contract, awarded on May 1, 2024, is structured as a firm fixed-price delivery order with an ultimate completion date of August 31, 2026. The place of performance is Lebanon, Pennsylvania. This award represents a child contract under Roche...
- Roche Diagnostics Corporation was awarded a $607,112.75 firm fixed-price blanket purchase agreement call for Ventana histology reagents by Veterans Integrated Service Network 1 (VISN 1), the Veterans Affairs organization serving the Northeast region. The award, issued on May 17, 2024, with an ultimate completion date of May 16, 2025, represents a child contract under a larger indefinite delivery vehicle and carries no set-aside designation. Performance will occur at Roche's facility in...
- The Department of Veterans Affairs, Veterans Integrated Service Network 10, awarded a delivery order to Roche Diagnostics Corporation for Ventana reagents and supplies with a ceiling value of $455,000. This firm fixed-price contract, awarded on October 20, 2025, has an ultimate completion date of October 19, 2026, and will be performed in Castleton, Indiana. The award represents a child contract under a larger acquisition vehicle and was not designated as a set-aside contract, indicating open...
- Roche Diagnostics Corporation was awarded a $235,218.49 firm fixed-price purchase order by Veterans Integrated Service Network 16 (VISN 16) on October 19, 2023, for service, maintenance, and supplies related to Roche Ventana equipment. The contract is set to be completed by September 30, 2025, and represents work to be performed in Castleton, Indiana. This procurement is unencumbered by set-aside restrictions, allowing Roche Diagnostics to compete openly in the federal marketplace. As a global...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a delivery order to Roche Diagnostics Corporation valued at $599,591.55 for Roche Ventana reagents and consumables during the ordering period ending January 31, 2027. This firm fixed price contract, awarded on February 1, 2026, with no set-aside designation, represents a child award under a larger contract vehicle and will be performed in San Antonio, Texas. Roche Diagnostics Corporation, a foreign-owned...
- Roche Diagnostics Corporation, headquartered in Indianapolis, Indiana, received a Blanket Purchase Agreement (BPA) call award from Veterans Integrated Service Network 1 (VISN 1) on May 17, 2026, for the supply of Ventana histology reagents. The contract carries a ceiling value of $599.9K under a firm fixed-price arrangement with no set-aside designation, indicating open competition in the federal marketplace. Performance will be fulfilled from the contractor's facility in Castleton, Indiana,...
- Roche Diagnostics Corporation received a $230,038.78 firm fixed-price delivery order from Veterans Integrated Service Network 17 (VISN 17) for NTX Ventana Reagents, with performance in Castleton, Indiana and an ultimate completion date of April 20, 2027. This delivery order, awarded on April 21, 2026, was competitively awarded without set-aside designation and represents a child contract under a larger indefinite delivery vehicle or blanket purchase agreement. The award funds Roche's supply of...
- Roche Diagnostics Corporation was awarded a definitive firm fixed-price contract by the Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22) on April 1, 2023, for laboratory maintenance services to be performed at a VA facility in Tucson, Arizona. The contract carries a ceiling value of $10,425.66 and is scheduled for ultimate completion by September 30, 2025. No set-aside designation was used in this award, indicating competition was open to all qualified vendors....
- This is a definitive, firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $654,145.50, is for Roche Ventana Special Stains base and 4 option periods, with a period of performance through September 30, 2024. The contract was awarded on October 1,...
- This is a federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the supply of ROCHE VENTANA REAGENTS. The contract was awarded by the Department of Veterans Affairs, specifically the Veterans Integrated Service Network 10, and has a ceiling value of $422,119.60. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of October 19, 2026. The award date was October 20, 2022, and there was no set-aside...
Roche Diagnostics Corporation received a firm fixed-price definitive contract award from Veterans Integrated Service Network 22 on May 1, 2026, for the Ventana Vantage Workflow System Upgrade and Service. The contract has a ceiling value of $63,447 and an ultimate completion date of April 30, 2031. The work will be performed in Tucson, Arizona. This award was made without set-aside designation, reflecting open competition. The Ventana Vantage system is a histology staining platform used in laboratory settings for tissue specimen preparation and analysis, a core diagnostic capability that supports pathology operations across VA medical facilities. This contract award is a child contract associated with Roche Diagnostics' broader indefinite delivery and blanket purchase agreement vehicles with the VA. VISN 22 maintains a $3.1 million blanket purchase agreement with Roche for immunohistochemistry and in-situ hybridization equipment and services through September 2030, of which this definitive contract represents a specific task order. The award demonstrates sustained demand for Roche's histology diagnostic solutions across the VA healthcare system and reflects the company's established role as a primary supplier of advanced laboratory diagnostic equipment and reagents to federal military and veterans healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 4/29/26 |